PlainRecalls
FDA Drug Critical Class I Terminated

Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.

Reported: September 30, 2020 Initiated: September 1, 2020 #D-1595-2020

Product Description

Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.

Reason for Recall

Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.

Details

Recalling Firm
The Protein Shoppe
Units Affected
21,511 tablets
Distribution
Nationwide in the USA
Location
Pharr, TX

Frequently Asked Questions

What product was recalled?
Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.. Recalled by The Protein Shoppe. Units affected: 21,511 tablets.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 30, 2020. Severity: Critical. Recall number: D-1595-2020.